FDA Lifts Diabetes Drug Hold

This is a news story, published by Yahoo, that relates primarily to Biomea Fusion news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

diabetes trial

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest oral diabetes drug news, elevated lab values news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

diabetes study

Reuters

•

US FDA lifts clinical hold on Biomea's diabetes trials

Summary

Nutrition label

78% Informative

Biomea Fusion said the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes.

The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug, BMF-219, in June due to liver toxicity concerns.

The company said a safety review of an ongoing study did not show the concerning safety signals seen in the type 2 diabetes trial.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech